Shelcal
$ 209,00 – $ 328,00Price range: $ 209,00 through $ 328,00
Super Tadapox
$ 102,00 – $ 545,00Price range: $ 102,00 through $ 545,00
Stalevo
$ 78,00 – $ 191,00Price range: $ 78,00 through $ 191,00
Stalevo is a specialized combination medication containing levodopa, carbidopa, and entacapone, primarily used to manage the symptoms of Parkinson’s disease. The formula works by increasing dopamine levels in the brain, which helps to significantly improve motor function and reduce tremors. This therapy is specifically designed for patients who experience “wearing-off” symptoms, where the effects of standard levodopa treatments begin to fade before the next dose. By maintaining more consistent levels of medication in the bloodstream, it helps provide smoother control over physical movements throughout the day. Regular use of this treatment effectively addresses common challenges such as muscle stiffness and slowness of movement, promoting enhanced mobility and coordination.
SKU:
Stalevo
Category: Other
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Stalevo belongs to a group of antiparkinsonian agents that combine three distinct pharmacologically active components into a single fixed-dose oral tablet. It is prescribed under medical supervision for patients diagnosed with idiopathic Parkinson’s disease who experience end-of-dose motor fluctuations.
As an FDA-approved prescription medication, Stalevo offers combination therapy designed to extend the therapeutic window of levodopa in the central nervous system. Treatment requires individualized clinical management by a licensed healthcare provider to determine appropriate dosage strengths and daily administration timing.
| Attribute | Details |
|---|---|
| Active Ingredients | Carbidopa, Levodopa, Entacapone |
| Therapeutic Class | Antiparkinsonian Agent (DOPA Decarboxylase Inhibitor / Dopamine Precursor / COMT Inhibitor) |
| Dosage Form | Film-coated oral tablet |
| Route of Administration | Oral |
| Prescription Status | Prescription (Rx only) |
| Storage Requirements | Controlled room temperature: 68°F to 77°F (20°C to 25°C) |
Clinical Overview and Administration
Main Uses and Mechanism of Action
Main uses: Stalevo is indicated for the treatment of adult patients with Parkinson’s disease who experience signs and symptoms of end-of-dose “wearing-off.” This phenomenon occurs when the symptom relief provided by standard levodopa and carbidopa combinations diminishes before the next scheduled dose. On one hand, traditional carbidopa/levodopa therapy provides essential dopamine replacement; on the other hand, rapid metabolism of levodopa can lead to unpredictable motor fluctuations over time. Stalevo is specifically used to replace immediate-release carbidopa/levodopa formulations when patients require the addition of entacapone to sustain motor symptom control.
How the drug works: The medication operates through three synergistic mechanism pathways. Levodopa serves as a metabolic precursor that crosses the blood-brain barrier, where central aromatic L-amino acid decarboxylase converts it into active dopamine to compensate for depleted basal ganglia levels. Carbidopa inhibits peripheral decarboxylase enzyme activity, preventing systemic conversion of levodopa outside the central nervous system. This reduces peripheral side effects such as severe nausea while increasing the amount of levodopa available to enter the brain. Entacapone acts as a selective, reversible inhibitor of catechol-O-methyltransferase (COMT), blocking the peripheral breakdown of levodopa into 3-O-methyldopa and extending its plasma survival.
What happens in the body: Following oral administration, levodopa, carbidopa, and entacapone are absorbed quickly from the gastrointestinal tract, reaching peak plasma concentrations within approximately one to two hours. The co-administration of entacapone with carbidopa and levodopa increases the area under the plasma concentration-time curve (AUC) of levodopa by approximately 35% to 40% and prolongs its plasma elimination half-life from approximately 1.3 hours to 2.4 hours. The clearance of these substances occurs via hepatic metabolism and renal excretion, with entacapone undergoing extensive biotransformation prior to elimination in urine and feces.
Dosing Schedule and Day-to-Day Use
Dosing schedule: The dosage of Stalevo must be individualized for each patient based on therapeutic response and clinical tolerance. Tablets are manufactured in multiple fixed-dose ratios (including formulations designated as Stalevo 50, 75, 100, 125, 150, and 200, which reflect the milligram strength of levodopa alongside proportional amounts of carbidopa and a standard 200 mg of entacapone). Patients must take only one tablet per dosing interval. The maximum total daily dose of entacapone delivered through Stalevo should not exceed 1,600 mg per day (equivalent to 8 tablets of any individual strength containing 200 mg entacapone).
Day-to-day use: Tablets should be swallowed whole with a full glass of water. Maintaining a consistent daily dosage schedule helps stabilize plasma concentrations and minimize off-period symptoms. Patients should refrain from crushing, breaking, or chewing the tablets, as altering the dosage form can disrupt the intended absorption rate of the active components.
Food and alcohol interactions: Dietary protein intake can influence treatment efficacy. High-protein meals can delay gastric emptying and compete with levodopa for transport across the intestinal mucosa and blood-brain barrier, potentially leading to delayed or reduced therapeutic absorption. Patients may benefit from discussing protein timing relative to medication schedules with their healthcare provider. Alcohol consumption should be avoided or strictly minimized, as alcohol can intensify central nervous system depression, drowsiness, and orthostatic blood pressure changes. Iron supplements or multivitamins containing iron must not be taken simultaneously, as iron forms non-absorbable chelates with levodopa and entacapone in the digestive tract.
If you skip a dose: If a scheduled dose is missed, it should be taken as soon as it is remembered, unless it is nearly time for the next scheduled dose. Patients should never take two doses simultaneously or consume extra tablets to make up for a missed dose. Maintaining consistent intervals between doses helps maintain stable motor symptom control.
Safety, Precautions, and Common Questions
Adverse Reactions and Drug Interactions
Adverse reactions: Clinical use of Stalevo involves a safety profile associated with elevated dopaminergic activity and COMT inhibition. Common adverse reactions include dyskinesias (involuntary muscle movements), hyperkinesia, nausea, dizziness, insomnia, and somnolence. A recognized and benign side effect resulting from entacapone metabolism is a brownish-orange discoloration of the urine. Less common but serious adverse events include severe diarrhea, orthostatic hypotension, sudden onset of sleep during daily tasks, vivid dreams, hallucinations, confusion, and impulse control disorders (such as pathologically increased urges to gamble, spend money, or binge eat).
What not to combine: Co-administration of Stalevo with non-selective monoamine oxidase (MAO) inhibitors (such as phenelzine or tranylcypromine) is contraindicated due to the risk of severe, potentially life-threatening hypertensive crisis. Antihypertensive agents may require dosage adjustments when prescribed alongside Stalevo, as dopaminergic therapies can potentiate hypotensive effects. Dopamine D2 receptor antagonists–including antipsychotic medications like haloperidol or risperidone, as well as metoclopramide–may diminish the clinical efficacy of levodopa. Co-administration with oral iron preparations significantly impairs the bio-availability of the active compounds.
Important Precautions and Storage
Important precautions: Patients treated with Stalevo must be monitored for falling asleep suddenly without prior warning signs while engaging in activities of daily living, including operating motor vehicles. Abrupt reduction of dosage or sudden discontinuation of Stalevo must be avoided, as rapid withdrawal of dopaminergic agents can trigger a symptom complex resembling neuroleptic malignant syndrome (NMS), characterized by high fever, severe muscle rigidity, altered consciousness, and autonomic instability. Caution is required in patients with pre-existing severe hepatic impairment, as reduced biliary clearance may elevate entacapone concentrations. Use during pregnancy or breastfeeding requires careful medical risk-benefit assessment by a qualified prescriber.
Storage and expiration: Stalevo tablets should be stored at controlled room temperature between 68°F and 77°F (20°C to 25°C), with permitted excursions between 59°F and 86°F (15°C to 30°C). The container must be kept tightly closed to protect the medication from light and excess moisture. Expired medications should be disposed of in accordance with local drug take-back programs or standard pharmaceutical disposal procedures.
Common Questions
Is urine discoloration normal while taking Stalevo?
Yes. Entacapone, one of the active ingredients in Stalevo, undergoes metabolic clearance that frequently imparts a harmless brownish-orange color to the urine. This change in color is non-toxic and does not indicate kidney damage or injury.
What should I do if involuntary movements worsen after starting treatment?
Involuntary movements, known clinically as dyskinesias, can develop or intensify because Stalevo enhances overall levodopa availability. If you notice an increase in abnormal, uncontrolled movements, contact your prescribing physician, who may adjust the individual dose or spacing of your administration schedule.
Why must iron supplements be taken at a different time than Stalevo?
Iron ions bind directly to levodopa and entacapone inside the stomach and intestines, forming chemical complexes that cannot be effectively absorbed into the bloodstream. To prevent reduced drug efficacy, iron supplements and Stalevo doses should be separated by at least two to three hours.
What risks are associated with stopping Stalevo abruptly?
Suddenly stopping Stalevo can precipitate a dangerous medical condition characterized by extreme muscle stiffness, high fever, rapid heart rate, and mental status changes similar to neuroleptic malignant syndrome. Any changes to your treatment regimen should occur gradually under direct medical direction.
This text is for informational purposes only and does not constitute individual medical advice. In accordance with FDA requirements.
Additional information
| Dosage |
200 mg + 100 mg + 25 mg |
|---|---|
| Package |
30 pills ,60 pills ,90 pills ,180 pills |
| Active Ingredient |
Levodopa, Carbidopa, Entacapone |
Related products
Amalaki
$ 42,00 – $ 72,00Price range: $ 42,00 through $ 72,00
Active substance: Amalaki (Emblica officinalis) Extract
More Details
This product has multiple variants. The options may be chosen on the product page
Arcalion
$ 25,00 – $ 50,00Price range: $ 25,00 through $ 50,00
Active substance: Sulbutiamine
More Details
This product has multiple variants. The options may be chosen on the product page
Cyclosporine
$ 43,00 – $ 216,00Price range: $ 43,00 through $ 216,00
Active substance: Cyclosporine
More Details
This product has multiple variants. The options may be chosen on the product page
Esbriet
$ 100,00 – $ 328,00Price range: $ 100,00 through $ 328,00
Active substance: Pirfenidone
More Details
This product has multiple variants. The options may be chosen on the product page
Folic Acid
$ 6,00 – $ 18,00Price range: $ 6,00 through $ 18,00
Active substance: Folic Acid
More Details
This product has multiple variants. The options may be chosen on the product page
Imusporin
$ 117,00 – $ 535,00Price range: $ 117,00 through $ 535,00
Active substance: Cyclosporine
More Details
This product has multiple variants. The options may be chosen on the product page
LDN
$ 81,00 – $ 266,00Price range: $ 81,00 through $ 266,00
Active substance: Naltrexone
More Details
This product has multiple variants. The options may be chosen on the product page
Modvigil
$ 61,00 – $ 759,00Price range: $ 61,00 through $ 759,00
Active substance: Modafinil
More Details
This product has multiple variants. The options may be chosen on the product page
